Premium
Less than two years ago, Cadila Healthcare Ltd acquired a majority stake in a pharmaceutical company in a bid to ramp up its exports to the US—its largest market. But now, it has changed tack. Mumbai-listed Cadila had hoped that its purchase of a 51% stake in Windlas Healthcare Pvt. Ltd ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
